Premium
Stability of lymphocytes and Epstein–Barr virus during red blood cell storage
Author(s) -
Qu L.,
Triulzi D. J,
Rowe D. T.,
Griffin D. L.,
Donnenberg A. D.
Publication year - 2007
Publication title -
vox sanguinis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.68
H-Index - 83
eISSN - 1423-0410
pISSN - 0042-9007
DOI - 10.1111/j.1423-0410.2006.00880.x
Subject(s) - cd19 , biology , epstein–barr virus , lymphocyte , red blood cell , virus , immunology , virology , cd3 , microbiology and biotechnology , flow cytometry , antigen , cd8
Background The Epstein–Barr virus (EBV) establishes and maintains latent infection in B lymphocytes of the healthy adults. Lymphocytes remain viable during red blood cell (RBC) storage. The effect of RBC storage on the stability of EBV‐infected B lymphocytes and EBV genome is not known. Study Design and Methods Eight randomly selected non‐leukoreduced AS‐5 RBC units were stored for 42 days under standard blood bank refrigerated at 1–6 °C. Cell count and EBV genomes in CD19+ B lymphocytes were measured in fresh products and weekly for 6 weeks. Total white blood cells (CD45+), T lymphocyte (CD3+), and B lymphocyte (CD19+) were quantified by a single platform flow cytometric assay. EBV genomes were quantified by real‐time polymerase chain reaction using DNA purified from CD19+ B cells. Results Viable white blood cell, T and B lymphocytes followed a biphasic decline curve during RBC storage consisting of a steep steady decline during the first 3 weeks followed by a plateau for the remainder of the storage. At the end of the RBC shelf‐life, 19% of the original T and B cells remained viable. EBV genomes per 10 5 CD19+ B lymphocytes remained constant during RBC storage. However, the total EBV genomes in the RBC units decline by more than 80% of their original value at the end of RBC storage due to loss of viable B lymphocytes. Conclusions The results indicate that lymphocytes and EBV latently infected B cells can survive the normal storage conditions for RBC.